Satsuma Pharmaceuticals Inc (STSA) has fallen Friday morning, with the stock decreasing -0.93% in pre-market trading to 1.06. STSA's short-term technical score of 72 indicates that the stock has traded more bullishly over the last month than 72% of stocks on the market. In the Biotechnology industry, which ranks 87 out of 146 industries, STSA ranks higher than 74% of stocks. Satsuma Pharmaceuticals Inc has risen 5.94% over the past month, closing at $1.04 on April 21. During this period of time, the stock fell as low as $1.03 and as high as $1.09. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.
STSA has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on STSA!